Poor outcome of patients with COVID-19 after CAR T-cell therapy for B-cell malignancies: results of a multicenter study on behalf of the European Society for Blood and Marrow Transplantation (EBMT) Infectious Diseases Working Party and the European Hematology Association (EHA) Lymphoma Group

JOURNAL ARTICLE published December 2021 in Leukemia

Authors: Anne Mea Spanjaart | Per Ljungman | Rafael de La Camara | Gloria Tridello | Valentín Ortiz-Maldonado | Alvaro Urbano-Ispizua | Pere Barba | Mi Kwon | Dolores Caballero | Pierre Sesques | Emmanuel Bachy | Roberta Di Blasi | Catherine Thieblemont | Friso Calkoen | Pim Mutsaers | Johan Maertens | Livia Giannoni | Emma Nicholson | Matthew Collin | Carlos Pinho Vaz | Elisabetta Metafuni | Joaquin Martinez-Lopez | Fiona L. Dignan | Josep-Maria Ribera | Arnon Nagler | Frantisek Folber | Robin Sanderson | Adrian Bloor | Fabio Ciceri | Nina Knelange | Francis Ayuk | Nicolaus Kroger | Marie José Kersten | Stephan Mielke